Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Internal Ventures Group Focusing On Skin Patch, Stem Cell Therapies

Executive Summary

Johnson & Johnson is using its J&J Internal Ventures group to identify and develop technologies to create a new skin patch

You may also be interested in...



Pfizer Sales Force Is “Critical” To Five-Year Strategy, McKinnell Says

Pfizer sees no need for significant changes to its sales force model for at least the next three to five years, CEO Hank McKinnell said Jan. 19

Rx Firms Can Use Repatriated Cash On Marketing, Mergers

The Treasury Department and Internal Revenue Service will allow manufacturers to use repatriated cash from overseas operations on marketing expenses and mergers

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Topics

UsernamePublicRestriction

Register

LL033172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel